Sectoral Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Sectoral Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290K	Sell	1,500 -240	-14%	-$41.5K	0.24%	71
2025 Q4	$318K	Buy	1,740 +720	+71%	+$101K	0.25%	69
2025 Q3	$124K	Hold	1,020	–	–	0.08%	81
2025 Q2	$106K	Hold	1,020	–	–	0.07%	93
2025 Q1	$119K	Buy	1,020 +200	+24%	+$22.8K	0.09%	77
2024 Q4	$69.4K	Buy	+820	New	+$75.4K	0.05%	85
2020 Q3	–	Sell	-4,200	Closed	-$346K	–	99
2020 Q2	$346K	Buy	+4,200	New	+$323K	0.03%	153

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sectoral Asset Management's AXSM Position: Q1 2026 in Review

Sectoral Asset Management reduced its Axsome Therapeutics (AXSM) stake by 14% in Q1 2026, selling an estimated $41.5K and leaving 1,500 shares worth $290K. The position accounts for 0.24% of the portfolio, ranked #71.

Sectoral Asset Management first reported a position in AXSM in Q2 2020 and has held it in 7 quarters since. The position peaked at $346K in Q2 2020. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Sectoral Asset Management held 1,500 shares of Axsome Therapeutics worth $290K as of Q1 2026.
Sectoral Asset Management sold 240 Axsome Therapeutics shares in Q1 2026, an estimated $41.5K.
Axsome Therapeutics made up 0.24% of Sectoral Asset Management's portfolio in Q1 2026, its #71 holding.
Sectoral Asset Management first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 7 quarters since.
Sectoral Asset Management's Axsome Therapeutics position peaked at $346K in Q2 2020.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.